Home Search

hapbee - search results

If you're not happy with the results, please do another search
Hapbee, Biotech Stock Review

Telehealth App Hapbee (HAPB) Goes Public and More.

1. Hapbee (HAPB) $0.30, Going Public.2. Saying Goodbye to Immunomedics (IMMU) $86.3. Adding Biosig (BSGM) $2.95, to Watch...
Hapbee,

Hapbee (HAPB) to Commence Trading on the TSX Venture Exchange.

VANCOUVER, BC, Oct. 28, 2020 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) ("Hapbee" or the "Company"), a wellness technology company developing the...
Hapbee, Biotech Stock Review

Video: Hapbee Testimonials.

Hapbee is powered by patented ultra-low radio frequency energy (ulRFE®) technology invented by...

Hapbee Closes $6.5 Million Private Placement and Provides Corporate Update.

VANCOUVER, BC, July 17, 2020 /PRNewswire/ - Hapbee Technologies, Inc. ("Hapbee" or the "Company"), a wellness technology company developing the revolutionary Hapbee wearable, is pleased to announce...
Hapbee

Augmentative Wearable Device, Hapbee, Receives Amazing Reviews by Testers.

Originally posted on MartechSeries. The innovative augmentative wearable device, Hapbee, has been giving testers a reason to be happy....

Hapbee Corporate Presentation. Private.

FOR INSTITUTIONAL USE ONLY.
Internet Stock Review

Stocks On The Move!

Citius (CTXR) up 19%, Draganfly (DFLYF) up 31%, urban-gro (UGRO) up 37%, Provention (PVRB) flip-flopping, Hapbee Technologies (HAPBF) up 26% and the...

Tiki Hut Fund. The Past Year’s Biggest Losers!

The Past Year's Biggest Losers! Here's an interesting look at the biggest losers...
Provention

Provention Bio (PRVB) Updates.

LATEST UPDATE July 13th, 2022, below. (2021) We're getting way too many calls on...
Internet Stock Review

The Buffett Indicator. Tighten Your Safety Belts..

GDP's $22 Trillion vs Total Stock Market Value (TMC) of $50 Trillion How Does This Compute (hint,...

Latest article

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...